Navigation Links
Spectros Signs New International Distribution Deals
Date:11/4/2009

PORTOLA VALLEY, Calif., Oct. 19 /PRNewswire/ -- Spectros, developer and manufacturer of advanced molecular sensing and imaging devices which shed light on life-threatening diseases, announced today that it has signed exclusive distribution deals for both its T-Stat® VLS Tissue Oximeter and Sensors. The markets covered include Australia, New Zealand, The Netherlands, Belgium, Luxembourg (Benelux), Suriname, Italy, France, Spain, Portugal, Poland, Greece, Turkey, and Russia. The values of the deals were not disclosed.

Founded in 1995, Spectros develops tissue oximeters and sensors for various uses with applications in critical care, gastroenterology, colon-rectal surgery, plastic surgery, and vascular surgery. T-Stat® VLS Tissue Oximeter is an FDA-approved and CE Marking device approved for neonatal, pediatric, and adult use.

"We are proud to be working with our new partners, Endovations in Australia, Fysicon Medical Technology in the Netherlands, and A.M.I. Italia s.r.l. in Italy, who are providing the T-Stat® franchise in their respective markets in order to realize our potential," said David Benaron, CEO of Spectros. "Support of our technology is a testament to their commitment to offering their healthcare communities with innovative and life-saving solutions," commented Robert Kum, director of commercial development.

The T-Stat® franchise includes the T-Stat® VLS Tissue Oximeter, utilizing Visible Light Spectroscopy (VLS), a multi-wavelength, noninvasive, continuous, real-time monitor of absolute hemoglobin oxygen saturation. The T-Stat® Sensors allow for ischemia monitoring in various applications, including critical care (neonatal, pediatric, and adult), gastroenterology (G.I. ischemia diagnosis), colon-rectal surgery (anastomosis), plastic surgery (free flaps), and vascular surgery (AAA, TAAA, and EVAR).

Based in Australia, Endovations Pty. Ltd. is a leader in the field of critical care, respiratory, anesthesia, and surgical applications. Endovations will distributor the T-Stat® VLS Tissue Oximeter and Sensors to the Australian and New Zealand markets.

Based in the Netherlands, Fysicon Medical Technology is a leader in the field of cardiology. The company will distribute the T-Stat® VLS Tissue Oximeter and Sensors to the Dutch, Belgium, and Luxembourgian (Benelux), and Suriname markets.

Based in Italy, A.M.I. Italia s.r.l. is a leader in the patient monitoring market. A.M.I. will distribute the T-Stat® VLS Tissue Oximeter and Sensors in Italy, France, Spain, Portugal, Poland, Greece, Turkey, and Russia.

About Spectros

Spectros markets advanced molecular sensing and imaging devices that shed light on ischemia and cancer. The company's lead product, the T-Stat Tissue Oximeter, was the first medical device FDA approved as sensitive to ischemia, an insufficient blood flow to tissue. T-Stat is the only commercially available tissue oximeter that utilizes state-of-the-art visible light spectroscopy (VLS) technology. In clinical use, T-Stat is a real-time, absolute, non-invasive, and continuous tissue monitor that analyzes 260 wavelengths of light, far more than the 2-4 wavelengths used in other monitors for superior accuracy. Spectros is also developing molecular diagnostic tools for breast and prostate cancer currently in phase I/II clinical trials supported by the National Cancer Institute. Spectros is a venture-supported private concern and markets its products in the U.S. and internationally. For further information, contact Elizabeth van Thillo, Marketing, Spectros Corporation, at info@spectros.com or 650/529.2865

SOURCE Spectros


'/>"/>
SOURCE Spectros
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. Spectros Signs New International Distribution Deals
2. Study identifies warning signs of pregnancy danger
3. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
4. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
5. Great Ape Trust signs agreement with Universitas Nasional in Jakarta
6. Umbilical cord blood cell therapy may reduce signs and symptoms of Alzheimers disease
7. bioMETRX, Inc. Signs Deal To Acquire Controlling Interest in Biometric Solutions, LLC
8. Unifying the animate and the inanimate designs of nature
9. University of Miami engineer designs stretchable electronics with a twist
10. Engineering technology pinpoints earliest signs of animal life
11. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... "Increase in mobile transactions is driving the ... market is expected to grow from USD 4.03 billion ... a CAGR of 29.3% between 2016 and 2022. The ... demand for smart devices, government initiatives, and increasing penetration ... is expected to grow at a high rate during ...
(Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... , ... January 23, 2017 , ... ... at the Caribbean Neurosciences Symposium (CANS) annual meeting in Montego Bay, Jamaica from ... and host a hands-on workshop for surgeons to experience the simplicity of the ...
(Date:1/21/2017)... ... January 20, 2017 , ... Nipro Corporation (Osaka, Japan) and ... under which Nipro will receive exclusive marketing and sales rights for all non-OEM Transonic ... for hemodialysis patients in Japan, the new Nipro - Transonic JV is a natural ...
(Date:1/21/2017)... 20, 2017 Bioptix, Inc. (Nasdaq: ... that on January 14, 2017 the Board of Directors ... Company will terminate certain employees associated with the September ... Company commenced terminations on January 16, 2017 and terminations ... Company may pay severance benefits in certain circumstances of ...
(Date:1/20/2017)... PA (PRWEB) , ... January 20, 2017 , ... The ... transforming healthcare treatment options for patients. Vironika, a spin out from The Wistar Institute, ... both taking lab space at 3624 Market Street. , Vironika is developing a ...
Breaking Biology Technology: